Cardio-Oncology Rehabilitation: Strategies for Cardiovascular Risk Reduction and Recovery in Cancer Survivors

Read full text
Authors: Wiktoria Michnowska, Paweł Pustuła, Ewa Szplit, Patryk Hebda, Bartłomiej Błaszkowski, Roman Cemaga, Maria C. Faber Krol, Adam Wolski, Mateusz Kubicki, Katarzyna Więckowska
Cited by: 0

Abstract

Background: Improved cancer survival has increased the number of survivors at risk of cardiovascular disease due to therapy-related cardiotoxicity. Pharmacological treatment alone often fails to address cardiovascular and functional impairments. Cardio-oncology rehabilitation (CORE) combines structured exercise with comprehensive cardiovascular risk management. Aim: To summarize current evidence on the role of CORE in cardiovascular risk reduction and functional recovery in cancer survivors exposed to cardiotoxic therapies. Materials and methods: A narrative review of PubMed, Scopus, and Google Scholar was performed, including randomized trials, observational studies, systematic reviews, meta-analyses, guidelines, and consensus documents focusing on adult cancer survivors. Results: Cancer survivors frequently exhibit elevated cardiovascular risk and reduced cardiorespiratory fitness. Exercise-based CORE programs consistently improve fitness, functional capacity, fatigue, and quality of life, with emerging benefits for cardiometabolic risk factors and vascular function. Evidence for reduced major cardiovascular events remains limited, although higher physical activity is associated with improved survival. Digital and hybrid CORE models appear feasible. Conclusions: CORE represents an effective strategy to enhance cardiovascular health and functional recovery in cancer survivors, though large trials are needed to confirm long-term outcomes.

Fields of Study & Subjects

Cancer survivorship and care Chemotherapy-induced cardiotoxicity and mitigation Cardiac Health and Mental Health

Publication details

Journal / source
Quality in Sport
Volume
51
Pages
68396–68396
Publication date
12 February 2026
Language
EN